Literature DB >> 22326547

Anti-leishmanial activity of alkaloidal extracts obtained from different organs of Aspidosperma ramiflorum.

Ananda de Castro Cunha1, Talita Perez Cantuaria Chierrito, Gerzia Maria de Carvalho Machado, Leonor Laura Pinto Leon, Cleuza Conceição da Silva, Julio Cesar Tanaka, Lauro Mera de Souza, Regina Aparecida Correia Gonçalves, Arildo José Braz de Oliveira.   

Abstract

The present study was designated to evaluate semi-quantitative antileishmanial activity of alkaloidal extracts that were obtained from 1g of different parts of Aspidosperma ramiflorum (leaves, roots, seeds, and stem barks). Alkaloidal extracts of barks and leaves presented a good activity against the extracellular form (promastigotes) of Leishmania (L.) amazonensis. It is known that compounds responsible for the antileishmanial activity in the alkaloidal extracts from A. ramiflorum are the monoterpenoid indole alkaloids ramiflorine A and ramiflorine B, therefore extracts obtained from different plant parts were analyzed by electrospray ionization mass spectrometry (ESI-MS) in order to evidence the presence of these bioactive alkaloids. Based on these findings, alkaloidal extract from leaves was fractionated on preparative thin-layer chromatography in a bioassay-guided fractionation affording individual purified ramiflorines A and B. Both ramiflorines A and B showed significant activity against Leishmania (L.) amazonensis (LD(50) values of 18.5±6.5μg/ml and 12.63±5.52μg/ml, respectively). Our results are showing that alkaloidal extract from leaves is a promising alternative to the use of stem barks from A. ramiflorum. Copyright Â
© 2011 Elsevier GmbH. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22326547     DOI: 10.1016/j.phymed.2011.12.004

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  7 in total

1.  Potential therapeutic use of herbal extracts in trypanosomiasis.

Authors:  Thaise L Teixeira; Samuel Cota Teixeira; Claudio Vieira da Silva; Maria A de Souza
Journal:  Pathog Glob Health       Date:  2013-12-19       Impact factor: 2.894

2.  Cyanobacteria, Lyngbya aestuarii and Aphanothece bullosa as antifungal and antileishmanial drug resources.

Authors:  Maheep Kumar; Manoj Kumar Tripathi; Akanksha Srivastava; Jalaj Kumar Gour; Rakesh Kumar Singh; Ragini Tilak; Ravi Kumar Asthana
Journal:  Asian Pac J Trop Biomed       Date:  2013-06

3.  Aspidosperma (Apocynaceae) plant cytotoxicity and activity towards malaria parasites. Part I: Aspidosperma nitidum (Benth) used as a remedy to treat fever and malaria in the Amazon.

Authors:  Julia Penna Coutinho; Anna Caroline Campos Aguiar; Pierre Alexandre dos Santos; Joaquim Corsino Lima; Maria Gabrielle Lima Rocha; Carlos Leomar Zani; Tânia Maria Almeida Alves; Antônio Euzébio Goulart Santana; Maria de Meneses Pereira; Antoniana Ursine Krettli
Journal:  Mem Inst Oswaldo Cruz       Date:  2013-12       Impact factor: 2.743

4.  Computational study to discover potent phytochemical inhibitors against drug target, squalene synthase from Leishmania donovani.

Authors:  Padmika Madushanka Wadanambi; Uthpali Mannapperuma
Journal:  Heliyon       Date:  2021-05-31

5.  Anti-malarial activity of indole alkaloids isolated from Aspidosperma olivaceum.

Authors:  Talita P C Chierrito; Anna C C Aguiar; Isabel M de Andrade; Isabela P Ceravolo; Regina A C Gonçalves; Arildo J B de Oliveira; Antoniana U Krettli
Journal:  Malar J       Date:  2014-04-14       Impact factor: 2.979

6.  Aspidosperma (Apocynaceae) plant cytotoxicity and activity towards malaria parasites. Part II: experimental studies withAspidosperma ramiflorum in vivo and in vitro.

Authors:  Anna C C Aguiar; Ananda C Cunha; Isabela Penna Ceravolo; Regina A Correia Gonçalves; Arildo J B Oliveira; Antoniana Ursine Krettli
Journal:  Mem Inst Oswaldo Cruz       Date:  2015-11       Impact factor: 2.743

7.  Design of commercially comparable nanotherapeutic agent against human disease-causing parasite, Leishmania.

Authors:  Anupriya Baranwal; Adarsh Kumar Chiranjivi; Ashutosh Kumar; Vikash Kumar Dubey; Pranjal Chandra
Journal:  Sci Rep       Date:  2018-06-11       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.